Clinical Trial

Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Survivors, AVATARS Trial

Recruiting
View on ClinicalTrials.gov →
Summary
This clinical trial tests the feasibility, usability and acceptability of a virtual art therapy assisted re-integration (AVATARS) intervention to improve biopsychosocial outcomes, such as anxiety, depression, resilience, emotional regulation, stress, and cognition, among adolescent and young adult (AYA) cancer survivors. AYA cancer survivors (especially those treated at adult cancer centers) historically experience worse psychosocial outcomes and lack age appropriate psychosocial support compared to older adult cancer survivors. Creative art therapy accesses the limbic system to provide a corrective emotional experience in response to trauma and can help patients visually express depression, anxiety, and existential fears, process traumatic events, and regain agency and control. The AVATARS intervention may be a feasible, useable and acceptable way to improve biopsychosocial outcomes among AYA cancer survivors.
Protocol Amendment History 3 changes
notable Enrollment increased: 20 -> 30 participants 2026-03-31
notable Primary completion pushed: 2026-07-15 -> 2027-07-15 2026-03-31
minor Completion pushed: 2026-07-15 -> 2027-07-15 2026-03-31
Trial Details
NCT Number NCT07089927
Lead Sponsor Mayo Clinic
Conditions Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm
Enrollment 30 participants
Start Date 2025-07-02
Primary Completion 2027-07-15 (estimated)
Study Completion 2027-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-30